Regulatory AI · Product
From pre-IND to full IND: extending MedNova
Extending a pre-IND analysis tool into a full-IND gap analysis workflow, with regulatory content supplied and reviewed by domain experts.
The challenge
A pre-IND tool is not enough for a full IND: the scope, document set and checkpoints are different. The product had to be rebuilt around IND scope without losing the traceability that makes findings usable.
What we built
Full-IND scope rules, checkpoints and anchors defined by a regulatory lead; a staged approach with gap analysis first; and a test corpus used to assess accuracy before any accuracy claim is made.
Key capabilities
Inside the solution.
Expert-authored rules
Scope rules and checkpoints defined by a regulatory lead.
Staged delivery
IND gap analysis first, drafting support second.
Evaluation first
No accuracy figures are published until the evaluation run is complete.
Outcome
In active development. Details will be updated as milestones are reached.
More work
Keep exploring.
Partnering intelligence platform for a top 3 Bay Area biopharma company
An enterprise AI platform that helps partnering and business development teams discover, evaluate and prioritize companies and assets.
Read case studyEnterprise agentic AI training assistant for a top 5 global software company
An AI-powered assistant that gives real-time technical support to hundreds of participants during enterprise training sessions.
Read case studyAI-enabled validation documentation for a global bioprocessing leader
Report generation for validation documentation, measured against the client’s own golden output, with a reproducible and traceable approach.
Read case studyStart a conversation
Have a workflow that AI should handle?
Tell us what you are working on. We will reply with questions or a proposed scope, and we are happy to sign an NDA first.